Main > GASTROENTEROLOGY > USA. E. DG>Treat.>Dopamine D2>



USA. E. DG>Treat.>Dopamine D2>'s subsections
(*) USA Approval Date: 2020. 06.19.
(*) USA Launch Date: 2020. 10.26
>Antagonist Nasal Spray
Company
Company Commercial Partner:
DG: Diabetic GastroParesis
Generic Name: Metoclopramide
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 11.16
RTM
RTM Web-Site

USA. E. DG>Treat.>Dopamine D2>'s products
This section has no products